9:15 AM ET
8-K
M&A Deal
Impact Biomedical M&A Deal with Zoar Limited
Impact Biomedical Inc. announced that the SEC has declared effective the Form F-4 registration statement for its proposed merger with Zoar Limited. A special meeting of stockholders to approve the business combination is scheduled for November 13, 2026, with the combined company expected to trade under the ticker symbol 'ZOAR'.
- Counterparty
- Zoar Limited